Advertisement · 728 × 90
#
Hashtag
#CompassPathwaysStock
Advertisement · 728 × 90
WealthWise
WealthWise
@wealthwise-dca.bsky.social
2 months ago
Post image

Compass Pathways announced that the US FDA has accepted its Investigational New Drug application for COMP360, a psilocybin-based therapy for PTSD.

#CMPS #Psilocybin #PTSD #CMPSStock #CMPSNews #CompassPathways #CompassPathwaysStock #CompassPathwaysNews #ClinicalTrial #COMP360 #FDAApproval
$CMPS

0 0 0 0
WealthWise
WealthWise
@wealthwise-dca.bsky.social
4 months ago
Post image

COMPASS PATHWAYS FAST-TRACKS COMP360 LAUNCH BY UP TO A YEAR

#CMPS #CMPSStock #CMPSNews #CMPSStockNews #CompassPathways #CompassPathwaysStock #CompassPathwaysNews #CompassPathwaysStockNews COMP360 #PsychedelicTherapy #MentalHealthInnovation #Biotech #Psilocybin

1 0 0 0
WealthWise
WealthWise
@wealthwise-dca.bsky.social
7 months ago
Post image

Compass Pathways shared updates on its clinical pipeline and regulatory progress, highlighting momentum around its lead candidate COMP360 for treatment-resistant depression (TRD).

#CMPS #CompassPathways #CMPSStock #CMPSNews #CMPSStockNews #CompassPathwaysStock #CompassPathwaysNews
$CMPS

0 0 0 0